Alois Jungbauer Selected Research

N- (2,3- dichloro- 4- hydroxyphenyl)- 1- methylcyclohexanecarboxamide

10/2014	Effect of nonpersistent pesticides on estrogen receptor, androgen receptor, and aryl hydrocarbon receptor.
1/2013	Endocrine disruptors fludioxonil and fenhexamid stimulate miR-21 expression in breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alois Jungbauer Research Topics

Disease

5	Infections 02/2024 - 01/2016
4	Neoplasms (Cancer) 04/2016 - 03/2003
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2014 - 12/2008
3	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2013
3	Insulin Resistance 01/2014 - 03/2012
3	Atherosclerosis 03/2010 - 12/2008
2	Necrosis 01/2020 - 12/2011
2	Teratoma (Teratoid Tumor) 05/2012 - 01/2010
2	Metabolic Diseases (Metabolic Disease) 01/2011 - 09/2009
2	Dyslipidemias (Dyslipidemia) 03/2010 - 12/2008
2	Cardiovascular Diseases (Cardiovascular Disease) 03/2010 - 09/2009
2	Weight Loss (Weight Reduction) 09/2009 - 12/2008
2	Hemophilia A (Haemophilia) 09/2007 - 11/2005
1	Virus Diseases (Viral Diseases) 02/2024
1	Crimean Hemorrhagic Fever 01/2018
1	Human Influenza (Influenza) 01/2016
1	Prostatic Neoplasms (Prostate Cancer) 10/2014
1	Weight Gain 03/2012
1	Inflammation (Inflammations) 03/2012
1	Type 2 Diabetes Mellitus (MODY) 01/2011
1	Hyperlipidemias (Hyperlipidemia) 03/2010
1	Obesity 12/2008
1	Hypertension (High Blood Pressure) 12/2008
1	Hyperglycemia 12/2008

Drug/Important Bio-Agent (IBA)

5	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2013 - 12/2008
3	Proteins (Proteins, Gene)FDA Link 02/2024 - 12/2021
3	CytokinesIBA 02/2024 - 03/2010
3	IsoflavonesIBA 12/2011 - 09/2009
2	VaccinesIBA 01/2018 - 01/2016
2	Hormones (Hormone)IBA 04/2016 - 12/2011
2	fludioxonilIBA 10/2014 - 01/2013
2	N- (2,3- dichloro- 4- hydroxyphenyl)- 1- methylcyclohexanecarboxamideIBA 10/2014 - 01/2013
2	LipidsIBA 01/2013 - 03/2010
2	Rosiglitazone (Avandia)FDA Link 01/2011 - 12/2008
2	Factor VIII (Coagulation Factor VIII)IBA 09/2007 - 11/2005
1	Measles VaccineIBA 02/2024
1	Monoclonal AntibodiesIBA 01/2023
1	pertuzumabIBA 01/2023
1	Trastuzumab (Herceptin)FDA Link 01/2023
1	Nucleocapsid ProteinsIBA 12/2021
1	Immunoglobulin G (IgG)IBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	SteroidsIBA 04/2016
1	Cell ExtractsIBA 04/2016
1	Immune Sera (Antisera)IBA 01/2016
1	Hemagglutinins (Hemagglutinin)IBA 01/2016
1	Peptides (Polypeptides)IBA 01/2016
1	AntigensIBA 01/2016
1	EpitopesIBA 01/2016
1	PesticidesIBA 10/2014
1	Progesterone Receptors (Progesterone Receptor)IBA 10/2014
1	Nuclear Respiratory Factor 1IBA 10/2014
1	Cyclin D1IBA 10/2014
1	Complement System Proteins (Complement)IBA 01/2014
1	Phytoestrogens (Phytoestrogen)IBA 01/2014
1	Androgen Receptors (Androgen Receptor)IBA 01/2013
1	Endocrine DisruptorsIBA 01/2013
1	Glucose Transporter Type 4IBA 01/2013
1	GlucosidasesIBA 01/2013
1	Androgen Antagonists (Antiandrogens)IBA 01/2013
1	CholesterolIBA 01/2013
1	Inflammation MediatorsIBA 03/2012
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 03/2012
1	GenisteinIBA 12/2011
1	Plant ExtractsIBA 12/2011
1	LigandsIBA 01/2011
1	PPAR alphaIBA 03/2010
1	Estrogens (Estrogen)FDA Link 09/2009
1	PPAR gammaIBA 12/2008
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 12/2008
1	Mediator Complex Subunit 1IBA 12/2008
1	AutoantibodiesIBA 09/2007
1	AntibodiesIBA 11/2005
1	ResveratrolIBA 03/2003

Therapy/Procedure

2	Cell- and Tissue-Based Therapy (Cell Therapy) 05/2012 - 01/2010
1	Traditional Medicine (Folk Remedies) 01/2013